For destinations where reliable refrigeration is uncertain, consider using personal cooling solutions and timing your medication removal from refrigeration to align with the 21-day room temperature window
This analysis was a prespecified secondary analysis of the SUMMIT Trial, which showed that the long-acting glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonist tirzepatide decreased risk of cardiovascular death or worsening heart failure (HF) in patients with (HFpEF). As it pertains to sex, the investigators noted that women outnumber men with HFpEF, and there are sexual dimorphisms in the relationships between body fat and pathophysiology in HFpEF that could influence response to tirzepatide. In the SUMMIT trial, the investigators analyzed 731 patients (338 men, 393 women) with class II-IV HFpEF and BMI of 30 kg/m 2 or greater
To block nonspecific binding, bovine serum albumin treatment was applied
Discard compromised vials rather than risk injecting damaged peptide
Both can affect digestion: You may experience changes in bowel movements, such as constipation or diarrhea, as your digestion slows down
Contact your GP if vomiting persists beyond 612 hours or if you experience hypoglycaemia symptoms whilst taking insulin or sulfonylureas
